Skip to main content
OpenTrials

Clinical trial condition

Hypopigmentation

Explore clinical trials studying Hypopigmentation. Study availability and eligibility vary by location and protocol.

221 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hypopigmentation trial results

Completed

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

NCT04052425

Conditions
Hypopigmentation, Non-Segmental Vitiligo, Pigmentation Disorders, +3 more
Locations
  • Cahaba Dermatology Hoover, Alabama, United States
  • Cognitive Clinical Trials Scottsdale Btc Ppds Scottsdale, Arizona, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • First Oc Dermatology Fountain Valley, California, United States
View all 57 locations
View Trial Details
Completed

Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo

NCT04530344

Conditions
Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations
  • Cahaba Dermatology Hoover, Alabama, United States
  • Desert Sky Dermatology Gilbert, Arizona, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Center For Dermatology Cosmetic and Laser Surgery Fremont, California, United States
View all 84 locations
View Trial Details
Completed

A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)

NCT04896385

Conditions
Hypopigmentation, Pigmentation Disorders, Skin Diseases, +2 more
Locations
  • First Oc Dermatology Fountain Valley, California, United States
  • UC Irvine Irvine, California, United States
  • George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Suny Downstate Medical Center Brooklyn, New York, United States
View all 13 locations
View Trial Details
Completed

Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases

NCT06324695

Conditions
Alopecia, Alopecia Areata, Atopic Dermatitis, +27 more
Locations
  • Deutscher Vitiligo-Bund e.V. Adelsdorf, Germany
  • Fachklinik Bad Bentheim, Fachbereich Dermatologie und Allergologie Bad Bentheim, Germany
  • Universitätsklinikum der Ruhr-Universität Bochum (UKRUB), Klinik für Dermatologie, Venerologie und Allergologie Bochum, Germany
  • Universitätsklinikum Hamburg-Eppendorf (UKE), Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP) Hamburg, Germany
View Trial Details
Completed

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

NCT02272998

Conditions
Albinism, Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions